Lupin Ltd gets USFDA approval for Cefdinir

Share this on your social network:
   Facebook Twitter Google+ Comments Mail

New Delhi, May 9: Lupin Ltd today said it has received approval from the US Food and Drug Administrative to sell its anti-infective drug Cefdinir in Oral suspension form.

The company's Cefdinir capsules and suspensions are the AB-rated generic equivalent of Abbott Laboratories Omnicef which had the US sales of 787 million dollars for the 12-month period ended December 31, 2006.

Last year, Lupin received approval for the capsule form of the drug and a milder oral suspension, a company statement said.

Cefdinir is indicated for the treatment of patients with mild to moderate infections caused by susceptible bacteria.


Please Wait while comments are loading...
Your Fashion Voice
Content will resume after advertisement